Boston Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-33,142
| Closed | -$4.34M | – | 647 |
|
|
2019
Q2 | $4.34M | Sell |
33,142
-14,591
| -31% | -$1.91M | 0.23% | 119 |
|
|
2019
Q1 | $6.45M | Buy |
47,733
+209
| +0.4% | +$28.3K | 0.33% | 82 |
|
|
2018
Q4 | $4.63M | Sell |
47,524
-2,236
| -4% | -$218K | 0.27% | 104 |
|
|
2018
Q3 | $6.92M | Sell |
49,760
-201,089
| -80% | -$28M | 0.3% | 89 |
|
|
2018
Q2 | $31.1M | Buy |
250,849
+81,478
| +48% | +$10.1M | 0.78% | 22 |
|
|
2018
Q1 | $18.9M | Buy |
169,371
+20,130
| +13% | +$2.24M | 0.48% | 55 |
|
|
2017
Q4 | $17.8M | Buy |
149,241
+4,315
| +3% | +$516K | 0.39% | 70 |
|
|
2017
Q3 | $20.3M | Sell |
144,926
-9,815
| -6% | -$1.38M | 0.46% | 60 |
|
|
2017
Q2 | $18.8M | Buy |
154,741
+345
| +0.2% | +$42K | 0.43% | 61 |
|
|
2017
Q1 | $18.7M | Buy |
154,396
+34,315
| +29% | +$4.16M | 0.44% | 57 |
|
|
2016
Q4 | $14.7M | Buy |
+120,081
| New | +$14.7M | 0.35% | 84 |
|